Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ESE-16

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background: 2-Methoxyestradiol (2ME2) is an endogenous metabolite of 17-β-estradiol with anti-proliferative and anti-angiogenic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2018
2018
2-methoxyestradiol (2ME) is an endogenous 17β-oestradiol metabolite that exerts antiproliferative, antiangiogenic and antitumour… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
2015
2015
Abstract Angiogenesis is a closely controlled biological process that takes place during fetal development of blood vessels and… Expand
2014
2014
Cancer is the second leading cause of death in South Africa. The critical role that microtubules play in cell division makes them… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Background2-Ethyl-3-O-sulphamoyl-estra-1,3,5(10)16-tetraene (ESE-16) is a unique, in silico-designed compound with possible… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2014
2014
Background2-Methoxyestradiol is known to have antitumour and antiproliferative action in vitro and in vivo. However, when 2… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Effects of estradiol analogues on blood : a pilot study This study demonstrated that both ESE-15-ol en ESE-16 have no effect on… Expand
2013
2013
The aim of this study was to characterize the in vitro action of 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10)16-tetraene (ESE-16) on… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 5
2013
2013
Background2-Methoxyestradiol has been shown to induce both autophagy and apoptosis in various carcinogenic cell lines. Although a… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5